Unknown

Dataset Information

0

A potential interaction between COMT and MTHFR genetic variants in Han Chinese patients with bipolar II disorder.


ABSTRACT: Bipolar II disorder (BP-II), characterized by recurrent dysregulation of mood, is a serious and chronic psychiatric illness. However, BP-II is commonly under-recognized, even in psychiatric settings. Because dopaminergic disturbance is thought to be involved in the development of bipolar disorder (BPD), it seems essential to investigate dopamine-related genes like the catechol-O-methyltransferase (COMT) gene, which are involved in dopamine metabolism, and the methylenetetrahydrofolate reductase (MTHFR) gene, which may affect COMT methylation and COMT function. The current study examined the association and interaction of the COMT Val158Met and MTHFR C677T variants with BP-II. Nine hundred seventy-eight participants were recruited: 531 with BP-II and 447 healthy controls. The genotypes of the COMT and MTHFR polymorphisms were determined using a polymerase chain reaction-restriction fragment length polymorphism analysis. Logistic regression analysis showed a significant interaction effect of the COMT Val158Met Val/Val genotype and the MTHFR C677T C/T + T/T genotype (P = 0.039) for the protective effect on the odds of developing BP-II. Our findings support preliminary evidence that the COMT and MTHFR genes interact in BP-II, and they imply the connection of both dopaminergic pathways and methylation pathways in the pathogenesis of BP-II.

SUBMITTER: Wang LJ 

PROVIDER: S-EPMC4351536 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

A potential interaction between COMT and MTHFR genetic variants in Han Chinese patients with bipolar II disorder.

Wang Liang-Jen LJ   Lee Sheng-Yu SY   Chen Shiou-Lan SL   Chang Yun-Hsuan YH   Chen Po See PS   Huang San-Yuan SY   Tzeng Nian-Sheng NS   Chen Kao Chin KC   Lee I Hui IH   Wang Tzu-Yun TY   Yang Yen Kuang YK   Lu Ru-Band RB  

Scientific reports 20150306


Bipolar II disorder (BP-II), characterized by recurrent dysregulation of mood, is a serious and chronic psychiatric illness. However, BP-II is commonly under-recognized, even in psychiatric settings. Because dopaminergic disturbance is thought to be involved in the development of bipolar disorder (BPD), it seems essential to investigate dopamine-related genes like the catechol-O-methyltransferase (COMT) gene, which are involved in dopamine metabolism, and the methylenetetrahydrofolate reductase  ...[more]

Similar Datasets

| S-EPMC2435104 | biostudies-other
| S-EPMC5936991 | biostudies-literature
| S-EPMC5068873 | biostudies-literature
| S-EPMC2674973 | biostudies-literature
| S-EPMC6616560 | biostudies-literature
| S-EPMC7414458 | biostudies-literature
| S-EPMC3995040 | biostudies-literature
| S-EPMC4211806 | biostudies-literature
| S-EPMC5562572 | biostudies-literature
| S-EPMC4101969 | biostudies-literature